Alivus Life Sciences Ltd.

Alivus Life Sciences has informed that the Fourteenth (14th) Annual General Meeting (‘AGM’) of the Company will be held on Monday, September 8, 2025, at 03:00 pm (IST) through Video Conferencing (‘VC’) or Other Audio-Visual Means (‘OAVM’), in accordance, with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (‘SEBI’). As informed earlier, the Board of Directors at its meeting held on May 15, 2025, had recommended a final dividend of Rs 5.00 per Equity share of Rs 2 each of the Company for the financial year ended March 31, 2025, for approval by the shareholders at the AGM. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company has fixed Monday, September 1, 2025, as the ‘Record Date’ for the purpose of determining the entitlement of Members to receive the aforesaid dividend for the financial year ended March 31, 2025. If the aforesaid dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on or after Friday, September 12, 2025. This will also be posted on the company’s website www.alivus.com

The above information is a part of company’s filings submitted to BSE.